CAPITAL WORLD INVESTORS – Regeneron Pharmaceuticals, Inc. Transaction History
CAPITAL WORLD INVESTORS portfolio value:
$4.28B
portfolio value
CAPITAL WORLD INVESTORS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.14% | -9.01K shares | 603.14M | $688.87 | 6.22M |
Q2 2022 | share | Increase | +4.79% | 284.77K shares | -469.95M | $591.13 | 6.23M |
Q1 2022 | share | Increase | +11.76% | 626.19K shares | 793.41M | $698.42 | 5.94M |
Q4 2021 | share | Increase | +0.07% | 3.63K shares | 142.47M | $642.51 | 5.32M |
Q3 2021 | share | Increase | +0.23% | 12.04K shares | 254.90M | $605.18 | 5.32M |
Q2 2021 | share | Decrease | -14.17% | -876.16K shares | 38.71M | $558.54 | 5.30M |
Q1 2021 | share | Decrease | -10.97% | -761.64K shares | -429.61M | $473.14 | 6.18M |
Q4 2020 | share | Increase | +4.54% | 301.39K shares | -363.85M | $483.11 | 6.94M |
Q3 2020 | share | Decrease | -4.20% | -290.98K shares | -605.80M | $559.78 | 6.64M |
Q2 2020 | share | Decrease | -2.77% | -197.92K shares | 842.11M | $623.65 | 6.93M |
Q1 2020 | share | Decrease | -14.39% | -1.19M shares | 354.44M | $488.29 | 7.13M |
Q4 2019 | share | Increase | +1.53% | 125.77K shares | 852.13M | $375.48 | 8.33M |
Q3 2019 | share | Increase | +1.32% | 106.81K shares | -258.72M | $277.4 | 8.20M |
Q2 2019 | share | Increase | +8.12% | 608.16K shares | -540.98M | $313 | 8.09M |
Q1 2019 | share | Increase | +6.58% | 462.47K shares | 450.82M | $410.62 | 7.49M |
Q4 2018 | share | Increase | +10.10% | 644.86K shares | 45.88M | $373.5 | 7.02M |
Q3 2018 | share | Increase | +5.31% | 322.05K shares | 488.09M | $404.04 | 6.38M |
Q2 2018 | share | Increase | +29.02% | 1.36M shares | 473.31M | $344.99 | 6.06M |
Q1 2018 | share | Decrease | -2.27% | -109.05K shares | -189.48M | $344.36 | 4.69M |
Q4 2017 | share | Decrease | -26.80% | -1.75M shares | -1.12B | $375.96 | 4.80M |
Q3 2017 | share | Decrease | -5.33% | -370.04K shares | -470.86M | $447.12 | 6.56M |
Q2 2017 | share | Decrease | -2.08% | -147.65K shares | 661.75M | $491.14 | 6.93M |
Q1 2017 | share | Decrease | -8.68% | -673.80K shares | -102.66M | $387.51 | 7.08M |
Q4 2016 | share | Decrease | -0.66% | -51.21K shares | -291.62M | $367.09 | 7.75M |
Q3 2016 | share | Increase | +6.60% | 483.91K shares | 581.31M | $402.02 | 7.81M |
Q2 2016 | share | Increase | +4.45% | 312.00K shares | 30.32M | $349.23 | 7.32M |
Q1 2016 | share | Increase | +3.09% | 210.15K shares | -1.16B | $360.44 | 7.01M |